The new logistics building and the areas for quality control, quality assurance, and administration are ready for occupancy. The commissioning of the production building is also within reach. This marked the start of an intensive phase at the site in the second quarter of 2025, characterized by relocations, technical approvals, commissioning, and qualification and validation processes.
With state-of-the-art process and plant technology, the group continues to pursue its goal of significantly increasing production capacity at the site while consistently implementing its own sustainability targets.
The investment underscores the Lipoid Group’s clear decision to strengthen the location in the long term and expand it in a future-proof manner.